Nikhil Gupta, CR Horizons, confirmed to speak at DDW Symposium
The DDW Turning Science into Business Symposium will take place at the Francis Crick Institute in London on Tuesday 4 November.

DDW is delighted to welcome Nikhil Gupta is Principal Scientist at the Cancer Research Horizons-AstraZeneca Functional Genomics Centre to the expert speaker line-up.
Gupta will be presenting Advancing oncology drug discovery through pooled CRISPR screening. He pioneered advanced CRISPR technologies to uncover novel cancer targets. He has over 18 years of expertise in stem cell biology, epigenetics, and cancer research and he leads transformative scientific innovation to accelerate healthcare advancements.
He will be joined by speakers from the University of Cambridge, Oxford University, Apollo Therapeutics, Gain Therapeutics, Milner Therapeutics Institute and Shift Bioscience.
This free half day event will feature:
- Six in-depth presentations from industry experts
- a panel discussion examining new processes and technology, with a focus on how they can create efficiencies and expedite the drug discovery process
- an opportunity for networking
Sponsors:
- Nuclera (lead sponsor)
- Collaborative Drug Discovery (coffee break sponsor)
- Thermo Fisher Scientific (sponsor)
Registration is now open and is subject to availability and eligibility.
